New test to study language development in youth with Down syndrome

A team led by UC Davis Health researchers tested and validated elaborated language sampling (ELS) as a set of procedures for collecting, measuring and analyzing the spoken language of youth with Down syndrome in a naturalistic setting. They found that ELS is a reliable and feasible tool that can be used to detect meaningful changes in communication skills of individuals with Down syndrome.

Read more

Study finds risk of leukemia higher than expected in children with Down syndrome

The risk of childhood leukemia among kids with Down syndrome is higher than predicted, according to a new study led by UC Davis and UC San Francisco researchers. Early diagnosis remains critical.

Read more

Long Wait Times Increase for Children Seeking Emergency Care for Mental Health

Rates of prolonged visits for pediatric mental health emergency department (ED) visits increased over a decade, in contrast to non-mental health visits for which visit times remained stable, according to a study published in the journal Pediatrics. From 2005-2015, rates of ED visits lasting over six hours for children presenting for mental health issues jumped from 16 percent to nearly 25 percent, while rates of visits lasting over 12 hours increased from 5 percent to nearly 13 percent.

Read more

The Lancet GH: COVID-19 pandemic worsened pregnancy outcomes for women and babies worldwide

Findings reveal overall increase in the chances of stillbirth and maternal death during the pandemic, but chances of pre-term birth decreased in high-income countries

Read more

Childhood Car Crash Inspires UC San Diego Alumni to Donate to Pediatric Research

UC San Diego alumni make a gift of $1 million towards first-of-its-kind pediatric research. The Cathy and Richard Tryon Pediatric Facial/Psychological Trauma Research Fund will support research at UC San Diego to benefit pediatric patients who have suffered from traumatic facial deformities.

Read more

FDA approvals strengthen Octapharma USA pediatric critical care product portfolio

Octaplas™ and fibryga® receive new product labeling following FDA’s approval of BLA supplements to update therapy research; FDA expands fibryga® indication to include treatment of children under 12 years of age

Read more

CHOP Researchers Find Supplement Prevents Strokes in Patients with Rare Genetic Disorder

Researchers have discovered that a widely used nutritional supplement may significantly reduce the risk of fatal strokes caused by a rare genetic disorder. Additionally, the findings suggest that the supplement could be used to both block precipitation of and break up the formation of amyloid plaque deposits, a common feature found in serious forms of dementia.

Read more